Moderate riskFDA DeviceClass II

Zimmer Persona Revision Femoral Distal Augment recalled for wrong component in package

Zimmer discovered that 12 units of the Persona Revision Trabecular Metal Femoral Distal Augment (Model 42-5572-066-10, Size 9/9+, 10mm thickness) contained an incorrect posterior augment component in the package instead of the correct distal augment. No patient injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Zimmer Biomet recalls

What to do

  1. If you received this product, do not use it and contact Zimmer immediately with your lot number (66232947) and UDI code.
  2. Verify the correct component is in your package before surgery.
  3. Return unused product to Zimmer for replacement.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Brand Name: Persona Revision Product Name: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
12
Illnesses reported
None reported
Manufactured in
1800 W Center St, N/A, Warsaw, IN, United States
Classification
Class II
Recall number
Z-2578-2026

In the FDA's words

Description
Brand Name: Persona Revision Product Name: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package. Lot Code: Model No. 42-5572-066-10 ; UDI-DI (01)00889024561014(17)331103(10)66232947 ; Lot number 66232947 Distribution: Refer to the attached ZFA 2026-00088_Initial Consignee List and ZFA 2026-00088_Initial Distribution History containing the distribution and the identification of the affected consignees. Affected quantity: 12
Hazard
Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package.

Related topics